Press / media

Together with Primogene GmbH, a Leipzig-based biotech company, the Fraunhofer Institute for Cell Therapy and Immunology IZI is investigating whether breast milk could be significant in the prevention of serious infections beyond infancy.

On April 1 and 2, 2025, Fraunhofer Institute for Cell Therapy and Immunology (IZI) hosted the AAV Meeting in Leipzig, which brought together researchers and representatives from business and the healthcare sector to exchange the latest findings and innovations in the field of AAV technologies.

Researchers have discovered and analyzed a rare, yet serious, side effect of an innovative treatment against leukemia. The results of this study have now been published by scientists from Leipzig University Hospital, the Fraunhofer Institute for Cell Therapy and Immunology, and Cologne University Hospital in the prestigious medical journal “Nature Medicine”.

Prof. Dr. Frank Emmrich, founder of the Fraunhofer Institute for Cell Therapy and Immunology IZI, was presented with the Leipziger Lerche award on January 31st, 2025. This award modelled on the famous "Leipzig lark" pastry is endowed by Verein Gemeinsam für Leipzig e.V.